
GeoVax to Announce Q2 2025 Financial Results and Corporate Update
GeoVax Labs, Inc. is set to disclose its second quarter 2025 financial outcomes and share a corporate update, highlighting its progress in vaccine and immunotherapy development for infectious diseases and cancer.
Read full story
























